Mahamaya Lifesciences
Open Date
11 Nov 2025
Close Date
13 Nov 2025
Min Investment
₹273600
Lot Size
2400 Shares
Issue Size
₹70.44 Cr
Price Range
₹108 - ₹114
Listing Date
Nov 18, 2025
IPO Doc
RHP PDFAbout Mahamaya Lifesciences
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration, and export of the finest crop protection products and bio-products for crop & soil health management and to help the farming community for more productivity.The company has developed considerable expertise in the manufacture of pesticide formulations and bulk products for Indian agrochemical companies and MNCs.It imports carefully researched molecules, gets them registered with the Central Insecticides Board, and sells them as technical and value-added formulations to domestic manufacturers and MNCs.The company has invested in global product registrations, with active markets including the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Mahamaya Lifesciences IPO - Issue Objectives
The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant. ₹29.42 crore will be used to establish a new manufacturing plant. The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery. The company will utilise ₹18 crore for funding working capital requirement Part of the IPO proceeds will be used for general corporate purposes
Purchase of equipment
5.83%
Capital expenditure
45.77%
Construction of warehouse building
3.94%
Working capital
28%
General corporate purposes
16.5%
Purchase of equipment
The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant.
Capital expenditure
₹29.42 crore will be used to establish a new manufacturing plant.
Construction of warehouse building
The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery.
Working capital
The company will utilise ₹18 crore for funding working capital requirement
General corporate purposes
Part of the IPO proceeds will be used for general corporate purposes
IPO Subscription Status
Financials of Mahamaya Lifesciences
In Cr.
Revenue: ₹84.04
EBITDA: ₹8.04
Profit: ₹4.10
| Key Performance Indicator | 30-Jun-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) | 31-Mar-23 (In Cr.) |
|---|---|---|---|---|
| Revenue | 84.04 | 267.17 | 162.83 | 137.40 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| Expenses | ||||
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Net Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves | 35.73 | 31.66 | 23.41 | 18.19 |
| Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
Mahamaya Lifesciences - Promoter(s)
Mahamaya Lifesciences
Krishnamurthy Ganesan Mrs
Lalitha Krishnamurthy Mr
N/A
N/A
Registrar Contact Details
Kfin Technologies Ltd
Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1, Delhi, New Delhi, 110020
Mahamaya Lifesciences IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 157.00 | |
 Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |
